PV Bulletin

Category

Company Watch

Pharmaceutical regulatory intelligence on company safety actions, recalls, label risk, and PV operations exposure for mid-market teams.

publicUpdated May 21, 2026

InSphero acquires PhenoVista, expanding 3D assay and imaging services

Urgency: High

This update requires triage for Risk Management, Vendor Oversight, Inspection Readiness; confirm local obligations and document follow-up actions.

Risk ManagementVendor OversightQPPV
SOP Impact4 SOPs
ConfidenceMedium
Relevant for: QPPV, Signal Management Lead, Labeling Lead
verifiedRegulatory action: Company Watch
Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only · workflow Inspection Readiness